Matthew A. Spear
2020
In 2020, Matthew A. Spear earned a total compensation of $614.9K as Former Chief Medical Officer at Poseida Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $172,000 |
|---|---|
| Salary | $430,000 |
| Other | $12,923 |
| Total | $614,923 |
Spear received $430K in salary, accounting for 70% of the total pay in 2020.
Spear also received $172K in non-equity incentive plan and $12.9K in other compensation.
Rankings
In 2020, Matthew A. Spear's compensation ranked 10,428th out of 13,090 executives tracked by ExecPay. In other words, Spear earned more than 20.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,428 out of 13,090 | 20th |
Division Manufacturing | 4,465 out of 5,621 | 21st |
Major group Chemicals And Allied Products | 1,852 out of 2,254 | 18th |
Industry group Drugs | 1,622 out of 1,954 | 17th |
Industry Biological Products, Except Diagnostic Substances | 366 out of 411 | 11th |
Source: SEC filing on April 27, 2022.
Spear's colleagues
We found two more compensation records of executives who worked with Matthew A. Spear at Poseida Therapeutics in 2020.